Ventas, Inc. - VTR STOCK NEWS

Ventas, Inc. (NYSE: VTR) has declared a quarterly dividend of $0.45 per common share, payable on July 14, 2021, to shareholders on record as of the close of business on July 1, 2021. Ventas operates within healthcare and real estate sectors, with approximately 1,200 properties as of March 31, 2021. The company focuses on generating consistent cash flows and superior returns through a diversified portfolio and partnerships with leading healthcare providers.

Ventas (NYSE: VTR) will present at the RBC Capital Markets Global Healthcare Conference on May 18, 2021, at 8:00 a.m. Eastern Time. The presentation will be available via webcast on the Company’s website at ir.ventasreit.com/events-and-presentations. Accompanying materials will also be accessible before the event, with the webcast replay archived for a limited time afterward. As of March 31, 2021, Ventas owns or has investments in approximately 1,200 properties, focusing on the healthcare and real estate sectors to provide strong cash flows and returns.

Ventas reported its first-quarter 2021 results, showing a significant recovery in its Senior Housing Operating Portfolio (SHOP). Occupancy rates improved by 190 basis points since mid-March, aided by successful vaccine rollouts. The company noted March and April were the first consecutive months with move-ins exceeding pre-pandemic levels. However, Net Income attributed to common stockholders fell to ($0.15) per share, a 112% decline from $1.26 in 2020. Nareit FFO decreased by 49% to $0.67 per share, while Normalized FFO also dropped by 26% to $0.72 per share.

Ventas, Inc. (VTR) will release its first quarter 2021 earnings before the NYSE opens on May 7, 2021. A conference call is scheduled for the same day at 10:00 a.m. ET to discuss the results. The dial-in number for the call is (833) 979-2853, with a passcode of 'Ventas.' An international line is available at +1 (236) 714-2928. There will also be a telephonic replay accessible from 1:00 p.m. ET that day for 30 days. Ventas operates as an S&P 500 real estate investment trust with approximately 1,200 properties under management.

Ventas, Inc. (NYSE: VTR) has declared a quarterly dividend of $0.45 per common share, payable on April 14, 2021 to stockholders of record as of the close of business on April 1, 2021. Ventas operates as a leading Real Estate Investment Trust (REIT), focusing on healthcare and real estate sectors, with a portfolio of approximately 1,200 properties. The company continues to manage its diversified portfolio effectively, catering to the aging population while ensuring consistent cash flows and returns for stakeholders.

Ventas (NYSE: VTR) announced management's presentation at the virtual Citi 2021 Global Property CEO Conference on March 9, 2021, at 2:00 p.m. Eastern Time. The webcast will be available on the Company’s website, along with accompanying materials accessible from March 8, 2021, at 8 a.m. Eastern Time. Ventas, a leading Real Estate Investment Trust (REIT) and S&P 500 company, focuses on the healthcare and real estate sectors, operating around 1,200 properties as of December 31, 2020, and aims to deliver consistent cash flows and shareholder returns.

Ventas, Inc. reports Q4 and full-year 2020 results, highlighting the positive performance of its Office and Triple-Net Healthcare businesses. Senior Housing Operating Portfolio (SHOP) occupancy declined due to the COVID-19 pandemic but is expected to improve as vaccination rates increase. The company ensured financial strength and flexibility, prioritized health and safety, and received ESG recognitions. Q1 2021 guidance reflects the ongoing impact of the pandemic.

Ventas, Inc. (NYSE: VTR) has appointed Maurice Smith, CEO of Health Care Service Corporation, as an independent member of its Board of Directors. Smith brings over 25 years of healthcare experience, having been recognized as one of Modern Healthcare's 100 Most Influential People. His expertise will be valuable as Ventas navigates post-Covid-19 challenges. With this appointment, the Board now comprises 12 directors, 11 of whom are independent, ensuring diverse perspectives and solid governance.